Grafa News and Videos — Page 99

• Target (NYSE:TGT) reported $26.5 billion in second-quarter net sales, up 5.3%, while $994 million in tariff refunds lifted diluted EPS to $4.11.
• Large U.S. value retailers are still growing sales, but profitability varies sharply as companies balance pricing, digital fulfillment and operating costs.
• Tariffs, fuel and freight costs, consumer price sensitivity and aggressive value positioning remain key variables for the sector through 2026.

• Gina Rinehart's Hancock Prospecting purchased eight million shares of SpaceX for US$1.37 billion. The firm stated this diversifies its portfolio away from Western Australian mining operations.
• The transaction drove a 72% increase in the firm's US equities portfolio to US$5.71 billion. These listed space peers share massive capitalisation metrics driven by institutional tech allocations.
• Developing orbital infrastructure requires extreme capital intensity. Aerospace executives project that scaling launch vehicles will demand continuous funding before reaching profitability.

• Klarna posted Q2 2026 revenue of $1.042 billion (+27%) and GMV of $36.6 billion (+18%), while turning a $46 million operating loss a year earlier into a $27 million operating profit and $9 million net income.
• Despite stronger profitability and transaction margins, Klarna cut its full‑year GMV outlook to $149–151 billion, citing weaker German consumer spending and ongoing sensitivity to credit conditions.
• Compared with peers, Klarna is larger than Affirm and Sezzle on GMV but faces similar pressure to show that higher per‑transaction economics can offset slower volume growth, while Block and PayPal embed BNPL within much broader payments ecosystems.

Scholar Rock (NASDAQ:SRRK) removed Catalent Indiana as a commercial fill-finish facility from its apitegromab Biologics License Application (BLA) for spinal muscular atrophy (SMA), with FDA review continuing using an alternate facility.

Yatra Online (NASDAQ:YTRA) confirmed that Magna Holdings launched an unsolicited tender offer to purchase up to 20 million ordinary shares of Yatra at $1.10 per share in cash.

Alvotech (NASDAQ:ALVO) entered a strategic licensing and commercialization agreement with Lotus Pharmaceutical covering two biosimilar candidates, AVT34 and AVT87, with potential value of approximately $150 million.

FedEx (NYSE:FDX) declared a quarterly cash dividend of $1.22 per share on common stock, payable on October 1, 2026, to shareholders of record as of September 14, 2026.

Vivakor (NASDAQ:VIVK) reported second-quarter 2026 revenue of $32.1 million, up 10% year over year, as expanded crude oil Supply & Trading activities supported growth.

reAlpha Tech Corp (NASDAQ:AIRE) completed its acquisition of InstaMortgage on August 19, 2026, adding direct mortgage lending capabilities to its real estate technology platform.

Milestone Pharmaceuticals (NASDAQ:MIST) enrolled the first patient in ReVeRA-301, a pivotal Phase 3 trial evaluating etripamil nasal spray for atrial fibrillation with rapid ventricular rate (AFib-RVR).